¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2024 ´ëÇÑÇ÷¾×ÇÐȸ ¼ºÀÎALL¿¬±¸È¸ Ãá°è ½ÉÆ÷Áö¾ö : 2024-04-20

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2024 ´ëÇÑÇ÷¾×ÇÐȸ ¼ºÀÎALL¿¬±¸È¸ Ãá°è ½ÉÆ÷Áö¾ö : 2024-04-20
±³À°ÀÏÀÚ : 2024-04-20
±³À°Àå¼Ò : ¼¼Á¾´ëÇб³ ´ë¾çAI¼¾Å¸ AIȦ

±³À°ÁÖÁ¦ : 2024 ´ëÇÑÇ÷¾×ÇÐȸ ¼ºÀÎALL¿¬±¸È¸ Ãá°è ½ÉÆ÷Áö¾ö

ÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¼ºÀÎALL¿¬±¸È¸

´ã´çÀÚ : ±èÇýÁø
¿¬¶ôó : 02-516-6581

À̸ÞÀÏ : hematology@kams.or.kr

±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú

Âü¼®¿¹»óÀÎ : 70¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 4 ½Ã°£ 20ºÐ

¼¼ºÎ¼ö°­·á : 50,000¿ø  

ºñ°í ºñȸ¿ø 50,000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 04¿ù 20ÀÏ AIȦ 10:00~10:30 "CAR T cell therapy in adult ALL(acute lymphoblastic leukemia) " ¹éµ¿ÈÆ(°æºÏÀÇ´ë)

±³À°½Ã°£ 04¿ù 20ÀÏ AIȦ 10:30~11:00 "ASH guidelines for adolescents and young adults ALL (acute lymphoblastic leukemia) " ±èµµ¿µ(ºÎ»êÀÇ)

±³À°½Ã°£ 04¿ù 20ÀÏ AIȦ 11:10~11:40 Recent diagnostic advances in adults ALL(acute lymphoblastic leukemia) ÀÌÁ¾¹Ì(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 04¿ù 20ÀÏ AIȦ 11:40~12:10 Recent therapeutic advances in adults ALL(acute lymphoblastic leukemia) ÀÌÁ¾Çõ(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 04¿ù 20ÀÏ AIȦ 13:10~13:50 Advances in gene-engineered immune cells of cancer therapy ÀÌÇý¼±(KAIST)

±³À°½Ã°£ 04¿ù 20ÀÏ AIȦ 13:50~14:30 Global trends of CAR T cell therapy in cancer Á¶¼öÈñ(CuroCell)

±³À°½Ã°£ 04¿ù 20ÀÏ AIȦ 14:50~15:05 Updated clinical outcomes & predictive factors to blinatumomab in patients with relapsed/refractory BCP-ALL ¹éµ¿¿ø(°æºÏÀÇ´ë)

±³À°½Ã°£ 04¿ù 20ÀÏ AIȦ 15:05~15:20 Phase II trial of Rituximab preconditioning for relapsed/refractory B-cell ALL treated with blinatumomab (RICOBAL) º¯ÀÚ¹Î(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04¿ù 20ÀÏ AIȦ 15:20~15:30 A phase 2 clinical trial to evaluate the efficacy of Venetoclax and Decitabine in relapsed/refractory adult T acute lymphoblastic leukemia/lymphoma (VEDETTE Study) ½Åµ¿¿±(¼­¿ïÀÇ´ë )

±³À°½Ã°£ 04¿ù 20ÀÏ AIȦ 15:30~15:40 Post-transplant therapy with hypomethylating agent in Philadelphia chromosome negative adult acute lymphoblastic leukemia ¹éµ¿¿ø(°æºÏÀÇ´ë)

±³À°½Ã°£ 04¿ù 20ÀÏ AIȦ 15:40~15:50 "Ponatinib based induction therapy followed by allogeneic stem cell transplantation with pre-emptive use of ponatinib for patients with Philadelphia positive B-cell acute lymphoblastic leukemia, prospective, multicenter study " ¹éµ¿¿ø(°æºÏÀÇ´ë )

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2024 ´ëÇÑÇ÷¾×ÇÐȸ ¼ºÀÎALL¿¬±¸È¸ Ãá°è ½ÉÆ÷Áö¾ö : 2024-04-20""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑÇ÷°ü¿Ü°úÇÐȸ16th Vascular Ultrasound Seoul Update 2023 Symposium (1ÀÏÂ÷) : 2024-04-20
´ÙÀ½±Û (¿Â¶óÀÎ) 2024³â ¼ÛÆı¸ÀÇ»çȸ Ãá°è ¿Â¶óÀÎ Çмú´ëȸ (4¿ù) : 2024-04-20 [1]
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20394 ¼­¿ï Á¦40ȸ ´ëÇѽŰæ°úÀÇ»çȸ Ãá°èÇмú´ëȸ : 2024-04-21 0 33 2024-04-15
20393 ¼­¿ï 2024 ´ëÇÑÄ¡¸ÅÇÐȸ Ãá°è Çмú´ëȸ : 2024-04-20 0 61 2024-04-15
20392 ¼­¿ï Á¦1Â÷ ±¹Á¦ÀÏÂ÷ÀÇ·áÇмú´ëȸ ¡¤ 2024³â ´ëÇÑ°¡Á¤ÀÇÇÐȸ Ãá°èÇмú´ëȸ 2ÀÏÂ÷ : 2024-04-20 0 40 2024-04-15
20391 ±¤ÁÖ ´ëÇѺñ´¢ÀÇÇÐȸ 2024 Á¦50ȸ Çѳ²Áöȸ Ãá°èÇмú´ëȸ : 2024-04-20 0 32 2024-04-15
20390 Á¦ÁÖ Á¦3ȸ ºñ´¢ÀÇÇаú º´¡¤ÀÇ¿ø °øµ¿ ½ÉÆ÷Áö¿ò : 2024-04-20 0 50 2024-04-15
20389 ¼­¿ï Á¦5ȸ Çѱ¹ ½Å»ý¾ÆÀü¹®¼Ò»ý¼ú (Korean Neonatal Advanced Life Support, KNALS) Instructor °úÁ¤ ½Ç±â±³À° : 2024-04-20 0 31 2024-04-15
20388 ¼­¿ï ´ëÇÑ°©»ó¼±¿µ»óÀÇÇÐȸ Á¦14Â÷ Çмú´ëȸ,2024 : 2024-04-20 0 46 2024-04-15
20387 ¼­¿ï ´ëÇÑÀü¸³¼±ÇÐȸ 2024 The 1st BPH Innovation Forum : 2024-04-20 0 48 2024-04-15
20386 ¼­¿ï Á¦1Â÷ ±¹Á¦ÀÏÂ÷ÀÇ·áÇмú´ëȸ ¡¤ 2024³â ´ëÇÑ°¡Á¤ÀÇÇÐȸ Ãá°èÇмú´ëȸ 1ÀÏÂ÷ : 2024-04-19 0 41 2024-04-15
20385 ¼­¿ï (¿Â¶óÀÎ) ÀÇ·á±â°ü Á¾»çÀÚ ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ½ÉÈ­±³À°(¼­½Ä ÀÛ¼º ½ÇÁ¦) : 2024-04-19 0 67 2024-04-15
20384 °æ±â ÇѸ²´ëÇб³µ¿Åº¼º½Éº´¿ø ³úÇ÷°ü ÁúȯÀÇ ÃֽŠġ·á update : 2024-04-19 0 100 2024-04-15
20383 ¼­¿ï ´ëÇѺñ°úÇÐȸ The 31th SNUH International Course on Endoscopic Surgery of the Nose and Paranasal Sinuses in conjunction with International Congress of ORL-HNS 2024 : 2024-04-19 0 61 2024-04-15
20382 ¼­¿ï ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ (¿Â¶óÀÎ) 4¿ù ¿ù·ÊÁý´ãȸ : 2024-04-18 0 53 2024-04-15
20381 ÀüºÏ ±º»ê½ÃÀÇ»çȸ ¿¬¼ö±³À°(°Ç°­°ËÁø°á°úÀÇ Çؼ®°ú ´ç´¢º´ ¿¹¹æ, ½ÄµµÁúȯ) : 2024-04-18 0 60 2024-04-15
20380 ¼­¿ï ´ëÇѽÅÀåÇÐȸ (¿Â¶óÀÎ) The 11th KSN Live Academy : 2024-04-18 0 56 2024-04-15
21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷